A family study of MNS system antigen polymorphism
Authors:
P. Papoušek 1; M. Kracík 2; I. Dolinová 2; L. Řehořová 1; R. Procházková 1,3
Authors‘ workplace:
Transfuzní oddělení, Krajská nemocnice Liberec, a. s.
1; Oddělení genetiky a molekulární dia gnostiky, Krajská nemocnice Liberec, a. s.
2; Fakulta zdravotnických studií, Technická univerzita v Liberci
3
Published in:
Transfuze Hematol. dnes,30, 2024, No. 2, p. 118-121.
Category:
Original Papers
doi:
https://doi.org/10.48095/cctahd2024prolekare.cz10
Overview
SUMMARY: Background: Mutations in the genes GYPA and GYPB encoding the MNS system can cause reduced to absent expression of antigens on the surface of red cells. This may lead to discrepant findings between immunohematological and genetic results. The aim of this study was to demonstrate that the discrepant finding in the investigation of MNS system antigens may be caused by a mutation in the GYPB gene and to investigate whether this mutation is also present in the patient‘s offspring. Materials and methods: In 2019, the extended MNS phenotype was examined by immunohematology using column and tube agglutination in patient A1 at the Transfusion Department of the Regional Hospital Liberec (KNL). These findings were confirmed at the Institute of Haematology and Blood Transfusion (IHBT) by column agglutination and genotyped by Fluogene PCR. In 2022, blood samples of patient A1‘s offspring were examined by immunohematological methods: phenotype by column agglutination and solid phase method at the Transfusion Department, KNL, and by column agglutination at the IHBT. Genetic testing was performed using real-time PCR ERY Q KKD/MNS-TYPE at the Department of Genetics and Molecular Diagnostics (OGMD), KNL, and by PCR methods: PCR Fluogene and ID CORE XT at the IHBT. Results: In patient A1, discrepant findings in antigen S were found: antigen phenotype S–s+ and genotype S+s+. All blood relatives of the patient (descendants) were examined – 9 in total (3 sons, 1 daughter, 4 grandchildren and 1 great-grandchild). The proband‘s descendants were found to have S+ or S– antigen, but there was never a discrepant result between immunological and genetic methods. Conclusion: In patient A1, a discrepant finding was observed in the results of the antigen S, which was most likely caused by a genetic change in the glycophorin B gene. This mutation was not passed on to any of the offspring.
Keywords:
red cell antigens – discrepant findings – family study
Sources
1. Masopust J, Písačka M. Krevní skupiny. In: Masopust J, Písačka M. Praktická imunohematologie – erytrocyty. 2. vyd. Praha, Grada, 2022; 39–153.
2. Menegati SFP, Santos TD, Macedo MD, Castilho L. Discrepancies between red cell phenotyping and genotyping in daily immunohematology laboratory practice. Transfus Apher Sci. 2020; 59: 102585. doi: 10.1016/j.transci.2019. 06.020.
3. GYPA glycophorin A [online]. [cit. 2023-12-17]. Dostupné z: https: //www.ncbi.nlm.nih.gov/ gene/2993.
4. GYPB glycophorin B [online]. [cit. 2023-12-17]. Dostupné z: https: //www.ncbi.nlm.nih.gov/ gene/2994.
5. Blood group database, MNS blood group [online]. [cit. 2023-12-17]. Dostupné z: https: //bloodgroupdatabase.org/groups/details/?group_ name=MNS.
6. Faria MA, Martins ML, Schmidt LC, Malta MC. Molecular analysis of the GYPB gene to infer S, s, and U phenotypes in an admixed population of Minas Gerais, Brazil. Rev Bras Hematol Hemoter. 2012; 34: 212–216. doi: 10.5581/1516-8484. 20120052.
7. Lapadat R, Anani WQ, Bensing KM, et al. A pair of S-silencing single nucleotide variants cis-linked on GYPB. Transfusion. 2021; 61: E34–E36. doi: 10.1111/trf.16357.
8. Homo sapiens glycophorin B (GYPB) gene [online]. [cit. 2023-12-17]. Dostupné z: https: //www.ncbi.nlm.nih.gov/nuccore/MK208314.
9. Westhoff CM. Molecular DNA-based testing for blood group antigens: recipient–donor focus. ISBT Science Series. 2013; 8: 1–5. doi: 10.1111/ voxs.12049.
10. Gleadall N. Donor characterisation: a novel platform for comprehensive genotyping, results from a large scale study. Vox Sang. 2019; 114 (Suppl 1): 25. doi: 10.1111/vox.12 792.
11. Gleadall NS, Veldhuisen B, Gollub J, et al. Development and validation of a universal blood donor genotyping platform: a multinational prospective study. Blood Adv. 2020; 4: 3495–3506. doi: 10.1182/bloodadvances.2020001894.
PODÍL AUTORŮ NA PŘÍPRAVĚ RUKOPISU
PP – příprava a provádění studie, sestavení rukopisu
MK, ID – vyšetřování, revize rukopisu
LŘ – zajištění imunohematologických vyšetřování, revize rukopisu
RP – příprava studie a revize rukopisu
Všichni autoři schválili finální verzi rukopisu.
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2024 Issue 2
Most read in this issue
- VEXAS syndrome – newly described autoinflammatory disease with haematologic symptoms. Case report and review of the literature
- VEXAS syndrome – a diagnosis at the interface of rheumatology and haematology
- Disorders induced by deposits of monoclonal immunoglobulin IgM and free light chain in Waldenström’s macroglobulinaemia – case report and review of literature
- Splanchnic vein thrombosis: aetiology, therapy, and results – a retrospective analysis